Where is the live CopyMark page for USPTO serial 79025255?

The live record is at https://getcopymark.com/trademark/79025255. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns NEUROPHARMA?

According to the public USPTO record for serial number 79025255, the listed owner(s) include: NOSCIRA, S.A, NEUROPHARMA, S.A., NEUROPHARMA, S.A., NEUROPHARMA, S.A., neuraxpharm Arzneimittel GmbH.

What is USPTO serial number 79025255?

Serial number 79025255 is the USPTO application identifier for the mark NEUROPHARMA. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover NEUROPHARMA?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: NEUROPHARMA Serial# 79025255 | status 404; last event DENC | Trademark Info & Attorney Guidance

Q: What is the current status of NEUROPHARMA?

NEUROPHARMA (79025255) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEUROPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

NOSCIRA, S.A
ES
Other trademarks owned by NOSCIRA, S.A
NEUROPHARMA, S.A.
E-28003 Madrid, ES
Other trademarks owned by NEUROPHARMA, S.A.
NEUROPHARMA, S.A.
E-28003 Madrid, ES
Other trademarks owned by NEUROPHARMA, S.A.
NEUROPHARMA, S.A.
E-28003 Madrid, ES
Other trademarks owned by NEUROPHARMA, S.A.
neuraxpharm Arzneimittel GmbH
DE
Other trademarks owned by neuraxpharm Arzneimittel GmbH

Goods and services

Class	Description	Status	First use
005	Pharmaceutical and veterinary preparations, in particular preparations for combating neuron diseases; natural and synthetic bioactive preparations for application in the fields of human or animal medicine, namely, pharmaceutical and veterinary preparations acting on the central nervous system; intermediate pharmaceutical and veterinary preparations, namely, anaesthetic and analgesic ingredients sold as components of pharmaceutical and veterinary preparations acting on the central nervous system and for combating neuron diseases	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 20, 2017	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Jan 20, 2017	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Apr 15, 2016	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Jul 17, 2015	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Jun 26, 2015	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Jun 26, 2015	INPC	INVALIDATION PROCESSED	—
Mar 26, 2015	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Feb 13, 2015	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Jun 13, 2014	C71T	CANCELLED SECTION 71	—
Mar 22, 2013	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Nov 1, 2010	CHLD	CHANGE OF OWNER RECEIVED FROM IB	—
Oct 23, 2009	CHLD	CHANGE OF OWNER RECEIVED FROM IB	—
Dec 14, 2008	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Feb 8, 2008	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Feb 8, 2008	FIMP	FINAL DISPOSITION PROCESSED	—
Feb 6, 2008	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Nov 6, 2007	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 21, 2007	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2007	NPUB	NOTICE OF PUBLICATION	—
Jul 13, 2007	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Jul 13, 2007	ALIE	ASSIGNED TO LIE	—
Jun 8, 2007	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jun 7, 2007	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jun 6, 2007	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 6, 2007	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2007	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Dec 29, 2006	RFNP	REFUSAL PROCESSED BY IB	—
Dec 11, 2006	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Dec 11, 2006	RFRR	REFUSAL PROCESSED BY MPU	—
Dec 7, 2006	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Dec 6, 2006	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2006	DOCK	ASSIGNED TO EXAMINER	—
Jul 28, 2006	NWAP	NEW APPLICATION ENTERED	—
Jul 27, 2006	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

NEUROPHARMA